Vincent R Anicetti is Chief Operating Officer of Coherus BioSciences, Inc.. Currently has a direct ownership of 124,790 shares of CHRS, which is worth approximately $264,554. The most recent transaction as insider was on Jul 06, 2021, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
0% 3M change
0% 12M change
Total Value Held $264,554

Vincent R Anicetti Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 06 2021
BUY
Grant, award, or other acquisition
-
50,000 Added 28.61%
124,790 Common Stock
Apr 28 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 21.41%
73,402 Common Stock
Mar 05 2021
SELL
Open market or private sale
$411,994 $15.46 p/Share
26,649 Reduced 33.29%
53,402 Common Stock
Mar 05 2021
BUY
Exercise of conversion of derivative security
$188,902 $9.3 p/Share
20,312 Added 20.24%
80,051 Common Stock
Feb 17 2021
SELL
Open market or private sale
$43,416 $17.45 p/Share
2,488 Reduced 4.0%
59,739 Common Stock
Feb 17 2021
BUY
Exercise of conversion of derivative security
$6,220 $2.5 p/Share
2,488 Added 3.84%
62,227 Common Stock
Jan 19 2021
SELL
Open market or private sale
$44,850 $17.94 p/Share
2,500 Reduced 4.02%
59,739 Common Stock
Jan 19 2021
BUY
Exercise of conversion of derivative security
$6,250 $2.5 p/Share
2,500 Added 3.86%
62,239 Common Stock
Jan 11 2021
BUY
Grant, award, or other acquisition
-
31,250 Added 34.34%
59,739 Common Stock
Jan 10 2021
SELL
Payment of exercise price or tax liability
$74,174 $18.18 p/Share
4,080 Reduced 12.53%
28,489 Common Stock
Dec 17 2020
SELL
Open market or private sale
$43,775 $17.51 p/Share
2,500 Reduced 7.13%
32,569 Common Stock
Dec 17 2020
BUY
Exercise of conversion of derivative security
$6,250 $2.5 p/Share
2,500 Added 6.65%
35,069 Common Stock
Dec 07 2020
SELL
Open market or private sale
$161,930 $18.42 p/Share
8,791 Reduced 21.25%
32,569 Common Stock
Dec 07 2020
BUY
Exercise of conversion of derivative security
$110,239 $12.54 p/Share
8,791 Added 17.53%
41,360 Common Stock
Dec 04 2020
SELL
Open market or private sale
$923,650 $18.85 p/Share
49,000 Reduced 60.07%
32,569 Common Stock
Dec 04 2020
BUY
Exercise of conversion of derivative security
$721,770 $14.73 p/Share
49,000 Added 37.53%
81,569 Common Stock
Dec 03 2020
SELL
Open market or private sale
$928,945 $18.67 p/Share
49,756 Reduced 60.44%
32,569 Common Stock
Dec 03 2020
BUY
Exercise of conversion of derivative security
$868,242 $17.45 p/Share
49,756 Added 37.67%
82,325 Common Stock
Nov 18 2020
SELL
Open market or private sale
$77,094 $18.0 p/Share
4,283 Reduced 11.62%
32,569 Common Stock
Nov 18 2020
BUY
Exercise of conversion of derivative security
$54,394 $12.7 p/Share
4,283 Added 10.41%
36,852 Common Stock
Nov 17 2020
SELL
Open market or private sale
$325,741 $17.62 p/Share
18,487 Reduced 36.21%
32,569 Common Stock
Nov 17 2020
BUY
Exercise of conversion of derivative security
$6,250 $2.5 p/Share
2,500 Added 4.67%
51,056 Common Stock
Oct 19 2020
SELL
Open market or private sale
$57,552 $17.89 p/Share
3,217 Reduced 6.21%
48,556 Common Stock
Oct 19 2020
BUY
Exercise of conversion of derivative security
$24,449 $7.6 p/Share
3,217 Added 5.85%
51,773 Common Stock
VRA

Vincent R Anicetti

Chief Operating Officer
Redwood City, CA

Track Institutional and Insider Activities on CHRS

Follow Coherus BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CHRS shares.

Notify only if

Insider Trading

Get notified when an Coherus Bio Sciences, Inc. insider buys or sells CHRS shares.

Notify only if

News

Receive news related to Coherus BioSciences, Inc.

Track Activities on CHRS